Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;21(12):827-828.
doi: 10.1038/s41575-024-00998-x.

Anticoagulants in cirrhosis: main concerns

Elena Campello  1 , Luca Fabris  2 , Paolo Simioni  2
Affiliations

Anticoagulants in cirrhosis: main concerns

Elena Campello et al. Nat Rev Gastroenterol Hepatol. 2024 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Eichholz, J. C., Wedemeyer, H. & Maasoumy, B. The challenge of anticoagulation in liver cirrhosis. Visc. Med. 39, 169–176 (2024). - DOI - PubMed
    1. Campello, E. et al. Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Liver Int. 41, 2455–2466 (2021). - DOI - PubMed - PMC
    1. Sinha, T. et al. Effectiveness of direct oral anticoagulants and vitamin K antagonists in preventing stroke in patients with atrial fibrillation and liver cirrhosis: a systematic review and meta-analysis. Cureus 16, e62606 (2024). - PubMed - PMC
    1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J. Hepatol. 76, 1151–1184 (2022).
    1. Bechmann, L. P. et al. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int. 31, 75–82 (2011). - DOI - PubMed

LinkOut - more resources